A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

NCT07180771 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral T Cell Lymphoma

Interventions

DRUG: BR101801

Sponsor

Boryung Pharmaceutical Co., Ltd